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Abstract
The pedunculopontine area (PPNa) including the pedunculopontine and cuneiform nuclei, belongs to the mesencephalic
locomotor region. Little is known about the oscillatory mechanisms underlying the function of this region in postural and
gait control. We examined the modulations of the oscillatory activity of the PPNa and cortex during stepping, a surrogate of
gait, and stance in seven Parkinson’s disease patients who received bilateral PPNa implantation for disabling freezing of gait
(FOG). In the days following the surgery, we recorded behavioural data together with the local field potentials of the PPNa
during sitting, standing and stepping-in-place, under two dopaminergic medication conditions (OFF and ON levodopa). Our
results showed that OFF levodopa, all subjects had FOG during step-in-place trials, while ON levodopa, stepping was
effective (mean duration of FOG decreasing from 61.7636.1% to 7.3610.1% of trial duration). ON levodopa, there was an
increase in PPNa alpha (5–12 Hz) oscillatory activity and a decrease in beta (13–35 Hz) and gamma (65–90 Hz) bands
activity. PPNa activity was not modulated during quiet standing and sitting. Our results confirm the role of the PPNa in the
regulation of gait and suggest that, in Parkinson disease, gait difficulties could be related to an imbalance between low and
higher frequencies.
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Introduction
In advanced stages of Parkinson’s disease (PD), gait disorders
such as freezing of gait (FOG) respond poorly to dopaminergic or
surgical treatment. FOG is defined as a sudden inability to start or
keep on walking, the patients describing their feet as glued to the
ground [1]. The pedunculopontine nucleus area (PPNa) has been
investigated as a new target for deep brain stimulation to treat gait
disorders in PD. The PPNa includes the pedunculopontine and
cuneiform nuclei and belongs to the mesencephalic locomotor
region (MLR) [2,3,4] Animal studies suggested that it plays a
major role in gait regulation and posture [5,6]. In PD it has been
reported that low frequency (between 10 and 70 Hz) chronic
stimulation of this area could improve gait disorders and FOG in
some, but not all, patients [7,8,9,10,11]. Functional imaging
studies have shown that gait imagery and PPNa stimulation were
associated with blood flow changes in the area of the MLR
[12,13,14]. Furthermore, microrecordings performed during
PPNa implantation have evidenced changes in neuronal activity
during mimicked steps [15]. However, the precise role of the PPNa
in gait control and FOG remains very elusive. Furthermore, it is
not clear why in some patients FOG is relieved under PPNa
stimulation, whereas others do not benefit from the procedure.
Regarding local field potentials (LFP), only one study recorded
activity in the PPNa during gait in parkinsonian patients OFF
levodopa [16]. These authors reported an increase in alpha (7–
10 Hz) oscillatory activity related to gait speed, further supporting
the idea that the PPNa plays a role in the regulation of gait in
humans as in animals. However, only one patient had FOG
episodes during the experiments, preventing group analysis of
PPNa oscillations during FOG. Therefore, our first aim was to
better describe the modulations of PPNa activity during FOG. We
reasoned that if the PPNa plays a role in FOG, the oscillatory
activity should be different between FOG episodes and fluent
stepping. Because of technical limitations (cable length), we could
not have the patients actually walk. We therefore used a step-in-
place (SIP) task as a surrogate. SIP has the same basic features as
gait: it involves rhythmic alternated stepping of the left and right
legs, requiring bilateral coordination of the legs in the single and
double phases of support, and shifting of the centre of mass over
the stance leg at each step in order to keep balanced. It is a form of
gait in which step length is reduced to 0. It has been shown to be
very effective to induce FOG [17,18] and to be strongly correlated
with patients’ self-report of FOG [18].
In addition, no study so far has studied the involvement of the
PPNa in stance control in humans. We therefore recorded the LFP
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activity of PPNa in PD patients at rest, during standing, and
during SIP. We reasoned that if PPNa is involved in balance
control in humans as in animals, we should see modulations in
LFP oscillatory activity during standing versus sitting.
Finally, so far, the influence of levodopa on the PPNa oscillatory
activity has been studied at rest and during self-paced upper limb
movements [19,20]. These authors reported that alpha activity
was only present under levodopa at rest, and that levodopa
increased the alpha peak preceding upper limb movement onset.
The influence of levodopa on gait-related PPNa oscillatory activity
has not been examined directly. In order to better understand the
influence of levodopa on PPNa activity during standing and gait,
or lack thereof, we tested patients both OFF and ON levodopa.
Because patients undergoing PPNa electrode implantation suffer
from levodopa-resistant FOG under chronic treatment condition,
we expected to see little levodopa-induced modulation of PPNa
oscillatory activities during SIP.
Methods
Patients
We included seven patients with PD and bilateral subthalamic
nucleus (STN) stimulation. The clinical characteristics of the
patients are shown in table 1. All patients underwent bilateral
PPNa stimulation because of severe FOG in spite of otherwise
efficient dopaminergic treatment and STN stimulation. Patient
6 had stopped taking levodopa for several years because of
dyskinesia and he was only evaluated OFF levodopa. The study
was approved by the Grenoble University Hospital Ethics
Committee and written informed consent was obtained from each
subject according to the Helsinki Declaration (trial: 06-CHUG-
21). The effects of PPNa stimulation on FOG at 1-year in six of
these patients have already been published [7].
Electrode Implantation
The surgical procedure has been published elsewhere [7].
Briefly, the PPNa was targeted bilaterally using stereotactic T1
and T2 brain MRI and contrast ventriculography to define the
bicommissural line and the fourth ventricle [15]. Intraoperative
microrecordings and microstimulation were performed along two
or three microelectrode trajectories. Quadripolar leads (DBS-
3389, Medtronic, Minneapolis, MN, USA) were implanted along
the trajectory with the greatest threshold for stimulation-induced
side effects and in which cells were recorded. The final location of
all contacts of the PPNa leads was checked using the coordinates of
each contact on the final intraoperative teleradiography (Pixray,
Bioscan system, Switzerland) plotted onto the preoperative
stereotactic MRI using an image navigation software (Osirix,
http://www.osirix-viewer.com) (Figure 1). The coordinates of the
tip of the distal contact of the electrodes implanted in the PPNa
are reported in table 2.
Electrophysiological Recordings
We recorded the LFP of the PPNa from the quadripolar leads
through extension cables four days after implantation and before
connection to the neurostimulator. The bipolar PPNa LFP activity
was recorded continuously from the adjacent four contacts
(contacts 0–1; 1–2; 2–3) of each deep brain stimulation lead
implanted in the PPNa. Cortical EEG activity was recorded from
Fz and Cz using needle electrodes with an ear reference, using an
audio–video–EEG monitoring system [SystemPlusTM software,
Micromed, Teviso, Italy]. The choice of mesial electrodes was
based on four arguments: 1) midline EEG is likely arising from the
pre-supplementary motor area and the precentral gyrus, thought
to be involved in locomotion [13], 2) gait and stance are
symmetrical bilateral motor skills involving the lower limbs, which
are represented along the mesial portion of the central sulcus, 3)
FOG could be related to disruptive connectivity between midbrain
locomotor regions and medial frontal regions [14,21], 4) these
electrodes were used by former authors to study cortico-subcortical
coherence [22,23,24,25]. All electrophysiological signals were
sampled at 512 Hz ([0.1–200 Hz bandwidth]). All recordings were
performed OFF STN stimulation.
Experimental Procedure
Patients performed two to four 30-seconds trials under each of
the following conditions: sitting at rest, standing and SIP. An
examiner stood close to the patient during the standing and SIP
recordings in order to prevent any fall. Assessments were first
carried out after an overnight fasting and withdrawal of
medication (OFF levodopa condition), and then repeated about
40 minutes after administration of 120% of the pre-surgery usual
Table 1. Patients’ characteristics.
Patient
Age at PD
onset (years)
Age at STN
surgery
Age at PPNa
surgery
Disease duration
(years)
LEDD
(mg) UPDRS III before PPNa surgery (/108)
OFF MED ON MED
OFF STN ON STN OFF STN ON STN
1 55 64 68 13 1025 49 22 22 24
2 50 64 68 18 550 62 57 52 45
3 49 65 72 23 800 38 19 29 30
4 44 53 57 13 1170 32 16 18 12
5 31 53 59 28 400 40 19 22 18
6 27 47 56 29 – 46 18 ND ND
7 36 52 61 13 800 63 32 23 10
Mean 41.7 56.9 63 21.3 790.8 47.1 26.1 27.7 23.2
SD 10.5 7.3 6.3 6.7 286.2 11.8 14.6 12.4 13
PD: Parkinson disease, STN: subthalamic nucleus, PPNa: pedunculopontine nucleus, LEDD: levodopa equivalent daily dose, MED: medication. ND: not done. Note that
the mean LEDD is computed for the 6 patients under dopaminergic medication only.
doi:10.1371/journal.pone.0083919.t001
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morning levodopa dose, so that patients were in their so-called
best-ON motor state (ON levodopa condition).
Behavioural Analyses
To record gait, inner soles (Stride Analyzer, B&L Engineering,
Santa Ana, CA, USA) containing four footswitches (one each for
the heel, big toe, first and fifth metatarsal heads), were placed in
the patients’ shoes. The foot-floor contact data were collected
using a telemetric acquisition system (Noraxon Telemyo 2400,
Scottsdale, USA) with video recording synchronization. Insole’s
recordings during SIP were obtained for five patients (because of
technical problems, data for patient 2 were lost). Patient 3 could
not perform the task because of major worsening of parkinsonian
symptoms when STN stimulation was switched OFF.
Recordings from the insoles were processed off-line. The
beginning and end of each FOG episode were marked on the
foot contact data. Freezing of gait episodes were defined as an
inability to perform effective stepping, i.e. completely lift the swing
foot from the floor, for at least two seconds [26,27]. This is easily
seen on the insoles’ recordings, as the switch signal will not drop to
0 as long as the patient’s foot rests on the floor (see figure 2). The
total duration of FOG for each trial was calculated as the sum of
all freezing episodes, and expressed relative to the total duration of
the trial (30 seconds), as percent. Our system did not enable
synchronization of the insoles and electrophysiological recordings.
Electrophysiological Analyses
Electrophysiological data were evaluated with custom-made
functions developed under MatlabTM (Matlab R2007b, The
Mathworks, Natick, MA, USA). For each of the six experimental
conditions, bipolar derivations were computed between adjacent
electrode contacts to suppress contributions from non-local
assemblies and ensure that the bipolar LFP signals could be
considered as originating from a volume in the vicinity of the two
contacts [28].
We computed the power spectrum of LFP and EEG signals, as
well as coherence between LFP and EEG, from all contact pairs
using fast Fourier transform and Hanning windowing. To obtain a
single value for cortex, we averaged together the power spectrum
and coherence estimated at Fz and Cz. Spectral analysis was
performed in the 1–90 Hz frequency range with a frequency
resolution of 1 Hz, using a time window of 2 seconds duration that
was moved every 0.2 s over the 30 s task periods. For each
hemisphere (n = 14), we then selected the contact-pair that had the
Figure 1. Localization of the DBS electrodes within the Pedunculopontine nucleus area (PPNa). A–B: Final intra-operative anteroposterior
and lateral teleradiographies in patient 1 (D). The two medial and posterior electrodes are implanted in the PPNa while the two anterior and lateral
leads are implanted in the subthalamic nucleus (STN). Note that the electrodes in PPNa are superimposed on the lateral view (see also Table 2). C:
schematic representation of brainstem coordinates calculation on the mid-sagittal plane according to pontomesencephalic landmarks. D-J : PPNa
DBS electrodes positions in the 7 patients on a 3D-T1-weighted magnetic resonance imaging reconstructed in the transverse plane of the brainstem
at the pontomesencephalic junction level (h : distance to the pontomesencephalic line; AC : anterior commissure; PC: posterior commissure. d :
orthogonal distance to the line prolonging the fourth ventricle line. V4: fourth ventricle).
doi:10.1371/journal.pone.0083919.g001
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highest power in the alpha band (5–12 Hz), or in the beta band
(13–35 Hz) if it was greater than in the alpha band [16]. We
ascertained that there was no laterality effect and then computed
relative power values in the alpha (5–12 Hz), beta (13–35 Hz) and
gamma (65–90 Hz) frequency bands on the 14 electrodes. To do
so, the average spectral power in each band was normalized by
dividing each frequency band power value by the average power
in the (5–90 Hz) frequency band. These relative power values
were used for statistical analyses.
Statistical Analyses
For each frequency band, we first examined the normality of
distribution using Kolmogorov-Smirnov test. Homogeneity of
variances was verified using a Bartlett test. As the assumptions for
parametric statistics were met, we compared the mean relative
power of the three different tasks (SIT, STAND and SIP) under
the two medication conditions (OFF and ON levodopa) using an
ANOVA with repeated measures. Post-hoc analyses were
performed using the Newman-Keuls test. A p value #0.05 was
considered significant. All statistical analyses were carried out
using the StatisticaTM software (Statistica, StatSoft, Tulsa, OK,
USA).
Results
Behavioral Data
Under OFF levodopa, all subjects had FOG during SIP trials
(figure 2). The mean duration of FOG episodes was 19610.6 s
(61.7635.3% of trial duration). ON levodopa, only 2 of the 5
patients had freezing episodes during the tests, reducing the mean
duration of freezing episodes to 363.2 s (7.3610% of trial
duration).
PPNa Oscillatory Activity
Visual inspection of all power spectrum computed during the
sitting trials revealed clear peaks in the alpha band (5–12 Hz) for
most contact pairs (11 out of 14 contacts), and in the beta band
(13–35 Hz) for the remaining three contact pairs.
Regarding the alpha band, the main effects of medication
[F(1,9) = 20.24; p,0.01] and task [F(2,18) = 10.26; p,0.01] were
significant, as was the interaction between the two factors
[F(2,18) = 14.17; p,0.001]. Examination of the origin of this
interaction showed that the alpha band power was significantly
greater under the SIP ON levodopa condition than under any
other condition (Newman-Keuls, p,0.01) (Figure 3 illustrates
PPNa recordings obtained during a SIP trial). In other words, the
alpha oscillatory activity was influenced by levodopa during the
SIP task only (figure 4).
In the beta band, as can be seen on figure 4, analysis revealed a
main effect of medication [F(1,9) = 13.74; p,0.01], beta power
decreasing under levodopa, as well as a main effect of task
[F(2,18) = 5.93; p,0.01]. Post-hoc analyses confirmed that,
whatever the medication condition, the power was significantly
reduced during the SIP task as compared to SIT and STAND
(Newman-Keuls, p,0.05).
In the gamma band, the main effect of task and the interaction
between task and medication were significant [Task:
F(2,18) = 3.84; p,0.05; Interaction: F(2,18) = 18.97; p,0.001].
Examination of the origin of this interaction showed that the
gamma band power was significantly reduced during SIP ON
levodopa as compared to all other conditions (Newman-Keuls,
p,0.01).
Cortical EEG Oscillatory Activities
There was no effect of task, medication or interaction between
task and medication in the alpha and beta bands (all p
values.0.11). In the gamma band, whatever the medication
condition, the power was significantly higher in the SIP condition
than in the SIT condition [F(2,8) = 5.6; p = 0.03].
Table 2. PPNa electrodes coordinates.
Pontomesencephalic line
Contact Laterality X (mm) Antero-posterior d (mm) Depth (rostro-caudal) h (mm)
Patient 1 0 5.3 8.7 1.5
4 6.0 8.7 1.5
Patient 2 0 6.7 9.5 0.8
4 7.5 9.5 0.8
Patient 3 0 5.7 7.7 21.3
4 5.5 7.7 21.3
Patient 4 0 2.6 6.5 22.9
4 5.0 6.1 22.9
Patient 5 0 4.7 8.9 21.7
4 5.4 8.4 21.7
Patient 6 0 4.5 9.8 21.1
4 4.9 9.8 21.1
Patient 7 0 4.5 5.1 2 4.21
4 7.0 5.1 2 4.21
The coordinates indicate the laterality of the tip of the distal contact of the right and left PPNa electrodes respectively; right and left distance (d) anterior to the line
extending from the floor of the 4th ventricle and the right and left distances to the pontomesencephalic (PM) line, defined as the line joining the pontomesencephalic
junction and the caudal quadrigeminal plate end measured on the midline (2: below this line; +: above this line).
doi:10.1371/journal.pone.0083919.t002
Pedunculopontine Nucleus Oscillations and Freezing
PLOS ONE | www.plosone.org 4 December 2013 | Volume 8 | Issue 12 | e83919
Figure 2. Foot switch recordings during a SIP trial OFF (upper panel) and ON (lower panel) levodopa (in patient 4). The voltage falls to
zero when the foot is lifted off the floor. Horizontal black bars above the graphs indicate freezing of gait (FOG) episodes. The incomplete lifting of the
foot when OFF DOPA reflects trembling FOG, i.e., the efforts of the patient to clear the foot from the floor when attempting to perform a step. ON
DOPA, notice that for the left foot, the voltage does not reach its maximal value on most steps. This reflects the fact that the patient only loads on his
forefoot when stepping.
doi:10.1371/journal.pone.0083919.g002
Figure 3. Pedunculopontine nucleus area (PPNa) oscillatory activity recordedduring a SIP trial, both OFF (A, LD-OFF) and ON
levodopa (B, LD-ON). A–B (from contact pair 1–2 in patient 6): Time–frequency maps. The vertical blue lines mark the beginning and end of the SIP
trial, preceded and followed by standing. Notice the increase in alpha and decrease in gamma spectral powers ON levodopa (B) during SIP vs. stand
immediately preceding and following stepping (i.e., compared with before and after the vertical blue lines).
doi:10.1371/journal.pone.0083919.g003
Pedunculopontine Nucleus Oscillations and Freezing
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PPNa-Cortex Coherence
We computed the average coherence between the PPNa contact
pairs of each subject’s hemisphere and Fz-Cz (Figure 5). In the
alpha band, there was a main effect of task on the PPNa-cortex
coherence [F(2,18) = 6.02; p,0.05]. Post-hoc analysis revealed
that, whatever the medication condition, the PPNa-cortex
coherence increased during the SIP task compared to SIT and
STAND (Newman-Keuls test p,0.05).
In the beta band, there was no effect of either medication, or
task.
Finally, in the gamma band, the effect of task was significant
[F(2,18) = 11.1; p,0.001]. Whatever the medication condition,
the coherence between PPNa and cortex increased during the SIP
and STAND tasks compared to SIT (Newman Keuls test;
p,0.01).
Discussion
We recorded the oscillatory activity of the PPNa and the cortex
during sitting, standing and step-in-place in parkinsonian patients.
The three main findings of our study are that: 1) alpha PPNa
oscillations (5–12 Hz) increased ON levodopa only, during SIP, 2)
PPNa gamma activity decreased from SIT to SIP, ON levodopa
only, and 3) regarding the PPNa-cortical coherence, it increased in
the alpha band during SIP and also increased in the gamma-band
during STAND and SIP compared to SIT. Before discussing the
significance of these results, we will examine the limitations of our
study.
Experimental Limitations
One limitation to this study is the number of patients included,
which does not afford a strong power to the statistical analyses.
However, PPN surgery currently remains experimental and our
sample size is comparable to, or even greater than, that of other
groups [16,19,20,29].
Another concern relates to the task used to study PPNa activity
during locomotion. Because of the limited length of the recording
wires, it was not possible to record the activity during actual
walking. However, we reasoned that SIP involved two of the major
features of gait, namely balance control and rhythmic alternated
activity of the two lower limbs. In fact, SIP resembles walking well
enough to induce FOG very effectively [7], as confirmed by the
behavioural results, with FOG occurring over 60% of the
stepping-in-place sequences when patients were OFF levodopa.
One could wonder why our patients were able to SIP ON
levodopa during the tests, although they were operated on in the
PPNa because of severe levodopa resistant FOG. Under usual
daily life conditions, these patients actually suffered from FOG
even ON levodopa. They were only able to SIP ON levodopa in
this experiment, because the recordings were performed after
administration of 120% of their usual levodopa equivalent
morning dose, that is, while patients were under their so-called
best-ON condition.
Unfortunately, our recording system did not enable synchroni-
sation of the foot insoles and brain recording, and we could not
compute correlations between FOG and oscillatory activity of the
PPNa. In addition, we analysed PPNa and cortical activities while
patients were either sitting or standing still in order to further
distinguish the activity related to balance control from that related
to stepping. Therefore the tasks used in this study enabled
examining the involvement of the PPNa activity in the regulation
of both balance and dynamical stepping.
Recordings were performed four days after surgery, and
therefore it is possible that the recorded LFP activities might be
altered by a microlesion effect, due to the short period between
electrode implantation and recordings [30,31]. Abosch et al.
showed that electrode impedance and beta-band amplitude were
Figure 4. Average alpha, beta and gamma frequency powers in the PPNa during sitting, standing and SIP (n=14 contact pairs). Error
bars indicate standard errors. OFF levodopa, the overall duration of freezing of gait was 61% of the trials’ duration. Note the increase in alpha power
when the patients manage to SIP while ON levodopa compared to OFF. There was a decrease in gamma power during SIP compared to standing and
sitting ON levodopa.
doi:10.1371/journal.pone.0083919.g004
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lower in long term recordings from implanted DBS electrodes, but
had a similar profile in response to movements as during acute
recordings [32]. Thus, although it is considered that results from
LFP analysis in the acute condition can be extended to the chronic
condition [32,33,34], one should be cautious in extending the low
frequency results of this study to the chronic stage.
Finally, one could wonder why our patients were able to SIP
ON levodopa during the tests, although they were operated on in
the PPNa because of severe levodopa-resistant FOG. Under usual
daily life conditions, these patients actually suffered from FOG
even ON levodopa. They were only able to SIP ON levodopa in
this experiment because the recordings were performed after
administration of 120% of their usual levodopa equivalent
morning dose, that is, while patients were under their so-called
best-ON condition.
Pedunculopontine Nucleus Activity at Rest
Intrinsic local field potentials of the PPNa. Several
authors have examined the electrophysiological characteristics of
the PPNa at rest in patients with PD [16,19,20,29,35,36].
Although there is no consensus on the electrophysiological
signature for the LFPs of the PPNa, previous studies reported
mainly alpha activity at rest with inconsistent beta activity
[16,19,20,29,35,36]. Our data recorded during sitting at rest are
congruent with these reports, as we observed alpha peaks in 11 out
of 14 electrodes and beta peaks in the remaining three. Aziz and
Stein [37] suggested that beta activity in the PPNa could
contribute to akinesia. In addition, a decrease, rather than an
increase, in the beta power has also been described in the STN of
PD patients, where this oscillatory activity is believed to have an
antikinetic effect [38]. Thus, the presence of beta activity OFF
levodopa and its decrease ON levodopa in the PPNa is congruent
with the previous hypotheses regarding the involvement of this
frequency band in parkinsonism.
The influence of levodopa on PPNa activity. Regarding
the influence of levodopa, it has been reported to enhance the
alpha and beta band oscillatory activities at rest in PD patients
implanted in the PPNa for gait disorders [19,20,29]. These
authors suggested that such modulation could have a physiological
role. However, our own data failed to fully replicate this effect.
While we observed an increase in alpha power activity under
levodopa, especially when the patients are active, the beta power
decreased ON levodopa as compared to OFF levodopa. Such
discrepancies between Androulidakis’ [19,20] and our results
could stem from differences in the experimental conditions,
patients’ characteristics and targeting.
Regarding patients’ characteristics, our patients had advanced
PD but were successfully treated by STN stimulation except for
severe FOG. The clinical and motor characteristics of these
patients, including young-onset of disease, STN stimulation- and
levodopa-responsive akineto-rigid syndrome with STN stimulation
and levodopa resistant axial symptoms, is not typical of the natural
evolution of PD but reflects the evolution of most PD patients with
STN stimulation [39,40,41,42]. They were offered PPNa surgery
because under usual dopaminergic treatment, their FOG was not
alleviated (contrary to what happens during a levodopa test based
on a medication dose exceeding the usual patient’s dosage) and
was their main complaint. It is not clear whether the patients of
Androulidakis et al. had levodopa-responsive or levodopa-resistant
FOG, which may be relevant to explain the differences in the
results of the two studies. In addition, because they were
successfully treated by STN stimulation, the usual levodopa daily
dose (about 800 mg) of our patients was smaller than that reported
for the patients included in Androulidakis’ studies (1000 to
1500 mg) [19,20]. Thus, it is possible that the amount of levodopa
used in the present study, although a largely supraliminal dose,
was not sufficient to alter the PPNa oscillatory activity at rest. Yet,
it was enough to alleviate FOG during the SIP task, confirming
Figure 5. PPNa-cortex coherence. Average (n = 14 contact pairs) alpha (A), beta (B) and gamma (C) frequency coherence between the midline
cortex and the PPNa during sitting, standing and SIP. Error bars indicate standard errors. Note a general trend to increasing coherence from sit to SIP
in the alpha band and from sit to stand and SIP in the gamma band. This effect is mainly observed OFF levodopa.
doi:10.1371/journal.pone.0083919.g005
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that the dosage was clinically relevant for these patients, as well as
able to significantly decrease beta activity.
Another difference between our and Androulidakis’s patients is
that ours were also stimulated in the STN, for an average of 6
years. Thus, one could envision that long term, plastic changes
brought about by chronic STN stimulation might have a bearing
on the present results. Yet, the literature on potential neuropro-
tective effects of DBS is very contradictory, and no report is
available regarding the influence of STN stimulation on PPNa
LFPs. In addition, while animal studies have documented bilateral
connections between the STN and PPN, electrophysiological
findings have yielded contradictory results. In humans, neuroan-
atomical, electrophysiological, and MRI probabilistic tractography
studies have failed to demonstrate such direct links [21,43,44,45].
Thus, hypothesizing that long term STN DBS did actually alter
the LFPs of the PPNa remains highly speculative.
Differences in electrode location could also contribute to the
divergent results across studies. Indeed, the actual PPN borders are
not clearly delineated in humans [46,47,48] and the anatomy and
atrophy of the mesencephalon may vary greatly from one brain to
another [49]. The most suitable target to treat FOG in the MLR
remains under debate and the localization of the electrodes within
the PPNa differs from one patient to another and from one study
to another [50,51,52]. Therefore we cannot exclude that
difference in electrodes location within the MLR contributed to
different outcomes across studies.
Pedunculopontine Nucleus and Cortical Activities during
Stand and Step-in-place Tasks
Regarding the influence of stepping movements, there was no
modulation of the alpha PPNa power (5–12 Hz) when patients
were mostly unable to perform the task OFF levodopa.
Thevathasan et al. also failed to observe any change in the alpha
power when PD patients walked OFF levodopa as compared to
rest [16]. However, one important difference between the two
studies is that the patients of Thevathasan et al. were able to walk
OFF levodopa, while ours were not [16]. Our patients were only
able to perform the task ON levodopa, and it was then associated
with an increase in alpha PPNa power. These results are not as
contradictory as they could seem at first sight. Indeed, Thevatha-
san et al. actually found a modulation of the alpha power when
patients were walking, as they reported a correlation between
alpha power and gait cadence on one hand, and an ‘‘attenuation
in alpha power’’ in one patient who experienced FOG during the
recordings on the other hand [16]. Thus, in the two sets of data,
alpha power is increased in relation to effective gait and is
comparatively reduced during FOG episodes. The main difference
between the two studies could simply be the severity of the gait
difficulties encountered by the patients.
At the behavioural level, the recorded modulation of the PPNa
activity ON levodopa during SIP was associated with a greater
success in performing the task, that is, a reduction of FOG
episodes. This suggests that the increased alpha power is related to
stepping rather than to freezing, in agreement with the results
reported by Thevathasan et al. [16]. In addition, we did not
observe any difference in alpha band activity when patients were
standing vs. sitting. Altogether, the data suggests that the low
frequency activity of the PPNa is related to the dynamical
component of gait, i.e., rhythmical stepping. Hence, the restora-
tion of gait ON levodopa in our patients could be related to the
increase in alpha power, if the mechanisms underlying alpha band
oscillatory activity are at least partly dopamine dependent.
Conversely, OFF levodopa, failure of alpha oscillatory activity
modulation could contribute to FOG.
In addition, we observed a decrease in beta band activity,
especially during the SIP task. The reduction of these antikinetic
oscillations under levodopa could contribute to the alleviation of
FOG.
Our study is the first study in which gamma band oscillations
were recorded within the PPNa. The PPNa gamma power
decreased under levodopa only, during effective stepping-in-place
compared to sit and stand. We did not observe any difference in
gamma band activity when patients were standing vs. sitting,
suggesting that the modulation of the high frequency activity of the
PPNa could be related to rhythmical stepping as alpha band
modulation.
The PPNa is not only involved in locomotion but is also part of
the reticular ascending arousal system. We previously demon-
strated that stimulating the PPNa could change alertness in some
patients [53]. As stepping requires more attention than sitting and
standing, and as levodopa may change alertness, it is possible that
levodopa-induced PPNa alpha and gamma band modulations
under levodopa are related to the increased alertness which may in
turn contribute to locomotion.
Analyses revealed that the coherence between the activity of the
PPNa and cortex in the alpha and gamma bands increased while
patients stepped-in-place, as compared to sit. This effect was
mainly observed when patients were OFF levodopa. Under this
medication condition, as the PPNa alpha and gamma powers were
respectively either unchanged or reduced by the task, the
increased coherence appears to reflect mainly an increase in the
phase-lock between the two structures. ON levodopa, the alpha
power increased in the PPNa during the stepping task. It is thus
not possible to know whether the increased coherence PPNa-
cortex is related to the change in alpha power or in the phase
locking between the PPNa and cortex oscillations. On the other
hand, the gamma power decreased ON levodopa during the
stepping task. This suggests that the increased coherence between
the PPNa and the cortical gamma oscillations reflects an increase
in the phase lock of these two structures. The hypothesis of phase-
locking of PPN/cortex oscillatory activity is further supported by a
recent study in MRI tractography showing a direct pathway
between PPNa and frontal cortical regions [21]. As this pathway
may be reduced in patients with FOG, it is likely that the estimated
changes of coherence may be lower than in physiological
conditions. This, together with our small sample size, may also
explain why we did not observe any laterality effect, unlike what
could be expected from the right-sided reduced connectivity
reported by Fling et al. [21].
Conclusion
In conclusion, we showed a reduced alpha band activity in the
PPNa when patients were unable to step because of severe FOG.
In contrast, under levodopa, that is, when patients were able to
step in place, there was a selective increase in alpha band activity
associated with a decrease in beta and gamma bands activity. We
did not expect such effects as our patients had mainly levodopa-
resistant FOG under chronic medication dosage. Yet, a higher
than usual levodopa dose was able to both alleviate FOG and
modify PPNa oscillatory activity. These results confirm the major
role of the PPNa in the regulation of locomotion, consistent with
the results of recent fMRI studies showing gait-related modulation
of brain activity in the region of the PPN [14,54]. They also
suggest that an increase of low frequency oscillations and/or
decrease in high frequency oscillations could be required to enable
walking, and that, in PD, an imbalance between high and low
frequencies could be responsible for the gait difficulties encoun-
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tered by the patients. FOG episodes could be associated with a
deficit in PPNa alpha power increase when patients attempt to
walk. Levodopa could alleviate this symptom by restoring a more
physiological modulation within the PPNa.
Finally, our results failed to reveal any specific modulation of the
PPNa activity during quiet standing as compared to sitting. This
reinforces the idea that the PPNa is mainly involved in gait
control. This is consistent with ours and others’ clinical data
showing an alleviation of FOG and falls related to FOG in some
patients, without effect on posture or postural stability [7,9].
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